210 results
-
List item
Human medicine European public assessment report (EPAR): Bonviva
ibandronic acid, Osteoporosis, Postmenopausal
Date of authorisation: 23/02/2004, Revision: 28, Authorised, Last updated: 29/03/2021Bonviva Musculoskeletal Diseases Bone … assessment report (EPAR) for Bonviva. It explains how the The committee … the conditions of use for Bonviva. What is Bonviva? Bonviva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Ibandronic Acid Teva
ibandronic acid, Breast Neoplasms; Neoplasm Metastasis; Fractures, Bone; Osteoporosis, Postmenopausal
Date of authorisation: 17/09/2010,
, Revision: 11, Authorised, Last updated: 06/09/2021
Acid Teva are Bondronat and Bonviva. What is Ibandronic Acid Teva … bioequivalent to Bondronat and Bonviva. Therefore, the CHMP’s view … that, as for Bondronat and Bonviva, the benefit outweighs the … -
List item
National expert: Paolo Porcelli, Italian Medicines Agency
- Declaration of interests - 79.77 KB | PDF
- Curriculum Vitae - 29.58 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Ibandronic acid Accord
ibandronic acid, Wounds and Injuries; Breast Diseases; Neoplastic Processes; Calcium Metabolism Disorders; Water-Electrolyte Imbalance
Date of authorisation: 18/11/2012,, Revision: 13, Authorised, Last updated: 12/04/2022
Accord are Bondronat and Bonviva. How is Ibandronic acid Accord … medicines, Bondronat and Bonviva, and do not need to be repeated … comparable to Bondronat and Bonviva. Therefore, the Agency’s … -
List item
National expert: Eraldo Donnarumma, Italian Medicines Agency
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 17.98 KB | PDF
PANORAMI E PERCORSI) "Doping: soluzione o inganno chimico? (BIF n.4/2006 … E PERCORSI) "Il corretto uso delle erbe medicinali" (BIF … -
List item
National expert: Tiziana Forte, Ministry for Health
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 24.01 KB | PDF
settembre 2002; "Acquisto soluzioni infusionali: parametri di … veterinari per le api e loro uso in campo" organizzato dal … -
List item
Press release: European Medicines Agency concludes class review of bisphosphonates and atypical fractures
CHMP, Last updated: 15/04/2011Adrovance, Bondenza, Bondronat, Bonviva, Fosavance, Ibandronic acid … Adrovance, Bondenza, Bondronat, Bonviva, Fosavance, Ibandronic acid … -
List item
Veterinary medicine European public assessment report (EPAR): Convenia
cefovecin (as sodium salt), Dogs; Cats
Date of authorisation: 19/06/2006, Revision: 13, Authorised, Last updated: 08/12/2020Usobacterium … -
List item
Press release: European Medicines Agency finalises review of medicines concerned by Roche pharmacovigilance inspection
Last updated: 19/11/2013Avastin, Bondenza, Bondronat, Bonviva, Cellcept, Fuzeon, Heceptin … Avastin, Bondenza, Bondronat, Bonviva, Cellcept, Fuzeon, Heceptin … -
List item
Direct healthcare professional communications
Last updated: 14/02/2020 -
List item
Press release: European Medicines Agency starts infringement procedure to investigate Roche's alleged non-compliance with pharmacovigilance obligations
Last updated: 23/10/2012Roche): EPAR Bondronat: EPAR Bonviva: EPAR CellCept: EPAR Fuzeon … Avastin, Bondenza, Bondronat, Bonviva, Cellcept, Fuzeon, Herceptin … -
List item
Referral: Bisphosphonates
alendronic acid, clodronic acid, etidronic acid, ibandronic acid, neridronic acid, pamidronic acid, risedronic acid, tiludronic acid, zoledronic acid, associated names: Actonel, Aredia, Bonefos, Didronel, Fosamax, Nerixia, Skelid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 13/07/2011, Last updated: 28/10/2011Bondenza: EPAR Bondronat: EPAR Bonviva: EPAR Fosavance: EPAR Ibandronic … zoledronic acid), Bondenza, Bonviva, Bondronat and Ibandronic … Adrovance, Bondenza, Bondronat, Bonviva, Fosavance, Ibandronic acid … -
List item
National expert: Raffaella Sardelli, Italian Medicines Agency
- Declaration of interests - 80.08 KB | PDF
- Curriculum Vitae - 22.93 KB | PDF
quot;Contaminazione da alluminio in soluzioni di albumina umana: un monitoraggio … dell'attivatore della precallicreina in soluzioni di albumina umana" (Abs … -
List item
National expert: Emilia Cercenado Mansilla, Spanish Agency of Medicines and Medical Devices
- Declaration of interests - 80.65 KB | PDF
- Curriculum Vitae - 231.8 KB | PDF
-
List item
National expert: Maria Jose Otero Lopez, European Medicines Agency
- Declaration of interests - 79.95 KB | PDF
- Curriculum Vitae - 23.06 KB | PDF
coordinator). Recomendaciones para el Uso Seguro del Potasio Intravenoso … SENSAR) e Instituto para el Uso Seguro de los Medicamentos … Lopez Organisation/Company: Instituto para el Uso Seguro de los Medicamentos Country … -
List item
National expert: María Belén Moyano Valerio, Spanish Agency of Medicines and Medical Devices
- Declaration of interests - 80.89 KB | PDF
- Curriculum Vitae - 17.17 KB | PDF
Española de Medicamentos y Uso Humano Country: Spain do … -
List item
Human medicine European public assessment report (EPAR): Fampyra (updated)
Fampridine, Multiple Sclerosis
Date of authorisation: 20/07/2011, Revision: 16, Authorised, Last updated: 05/05/2022 -
List item
National expert: Sigita Burokiene, Lithuania States Medicines Control Agency
- Declaration of interests - 79.86 KB | PDF
- Curriculum Vitae - 21.08 KB | PDF
Burokaite E, erkauskiene R, Usonis V. Factors determining parents decisions … 23:4141-4148. 5. Sviestina I, Usonis V, Gurksniene V, Burokiene … Raistenskis J, Burokait E, Usonis V. Unscheduled return visits … -
List item
National expert: Armando Magrelli, Italian Medicines Agency
- Declaration of interests - 79.8 KB | PDF
- Curriculum Vitae - 28.19 KB | PDF
Medicines Agency Con Soluzioni Con Srl (Italy) Main activities … -
List item
Human medicine European public assessment report (EPAR): Cinryze (updated)
C1 inhibitor (human), Angioedemas, Hereditary
Date of authorisation: 15/06/2011,
, Revision: 22, Authorised, Last updated: 20/05/2022
-
List item
National expert: Francesca Rocchi, Italian Medicines Agency
- Declaration of interests - 80.76 KB | PDF
- Curriculum Vitae - 27.62 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Bavencio (updated)
avelumab, Neuroendocrine Tumors
Date of authorisation: 18/09/2017,, Revision: 12, Authorised, Last updated: 26/04/2022
-
List item
Veterinary medicine European public assessment report (EPAR): Evant
Eimeria acervulina, strain 003, Eimeria maxima, strain 013, Eimeria mitis, strain 006, Eimeria praecox, strain 007, Eimeria tenella, strain 004, Chicken
Date of authorisation: 05/02/2019, Revision: 1, Authorised, Last updated: 04/03/2022 -
List item
Human medicine European public assessment report (EPAR): Bondronat
ibandronic acid, Hypercalcemia; Breast Neoplasms; Neoplasm Metastasis; Fractures, Bone
Date of authorisation: 25/06/1996, Revision: 31, Authorised, Last updated: 24/03/2021 -
List item
National expert: Antonio Portolés, Spanish Agency of Medicines and Medical Devices
- Declaration of interests - 82.87 KB | PDF
- Curriculum Vitae - 41.71 KB | PDF
A. Racionalizacion en el uso de somatostatina: implicaciones …